Follow
Joan Anton Puig Butille, Phd
Joan Anton Puig Butille, Phd
Head of Molecular Biology CORE laboratory, Hospital Clinic Barcelona
Verified email at clinic.cat
Title
Cited by
Cited by
Year
Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents
AM Goldstein, M Chan, M Harland, NK Hayward, F Demenais, DT Bishop, ...
Journal of medical genetics 44 (2), 99-106, 2007
5232007
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
AM Goldstein, M Chan, M Harland, EM Gillanders, NK Hayward, MF Avril, ...
Cancer research 66 (20), 9818-9828, 2006
5042006
Genome-wide association study identifies three new melanoma susceptibility loci
JH Barrett, MM Iles, M Harland, JC Taylor, JF Aitken, PA Andresen, ...
Nature genetics 43 (11), 1108-1113, 2011
2932011
Update in genetic susceptibility in melanoma
M Potrony, C Badenas, P Aguilera, JA Puig-Butille, C Carrera, J Malvehy, ...
Annals of translational medicine 3 (15), 2015
2742015
TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
KG Griewank, R Murali, JA Puig-Butille, B Schilling, E Livingstone, ...
Journal of the National Cancer Institute 106 (9), dju246, 2014
2692014
Benefits of total body photography and digital dermatoscopy (“two-step method of digital follow-up”) in the early diagnosis of melanoma in patients at high risk for melanoma
G Salerni, C Carrera, L Lovatto, JA Puig-Butille, C Badenas, E Plana, ...
Journal of the American Academy of Dermatology 67 (1), e17-e27, 2012
2642012
Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma
MH Law, DT Bishop, JE Lee, M Brossard, NG Martin, EK Moses, F Song, ...
Nature genetics 47 (9), 987-995, 2015
2482015
Genome-wide association meta-analyses combining multiple risk phenotypes provide insights into the genetic architecture of cutaneous melanoma susceptibility
MT Landi, DT Bishop, S MacGregor, MJ Machiela, AJ Stratigos, P Ghiorzo, ...
Nature genetics 52 (5), 494-504, 2020
1592020
A variant in FTO shows association with melanoma risk not due to BMI
J Randerson-Moor, C Requena, L Rivoltini, M Rodolfo, M Santinami, ...
Nature genetics 45 (4), 428-432, 2013
1352013
The effect on melanoma risk of genes previously associated with telomere length
MM Iles, DT Bishop, JC Taylor, NK Hayward, M Brossard, AE Cust, ...
Journal of the National Cancer Institute 106 (10), dju267, 2014
1332014
Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways
DL Duffy, G Zhu, X Li, M Sanna, MM Iles, LC Jacobs, DM Evans, S Yazar, ...
Nature communications 9 (1), 4774, 2018
1062018
Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: implications …
M Potrony, JA Puig-Butillé, P Aguilera, C Badenas, C Carrera, J Malvehy, ...
Journal of the American Academy of Dermatology 71 (5), 888-895, 2014
802014
Cell-type–specific eQTL of primary melanocytes facilitates identification of melanoma susceptibility genes
T Zhang, J Choi, MA Kovacs, J Shi, M Xu, AM Goldstein, AJ Trower, ...
Genome research 28 (11), 1621-1635, 2018
772018
Capturing the biological impact of CDKN2A and MC1R genes as an early predisposing event in melanoma and non melanoma skin cancer
JA Puig-Butille, MJ Escámez, F Garcia-Garcia, G Tell-Marti, À Fabra, ...
Oncotarget 5 (6), 1439, 2014
732014
Genetic abnormalities in large to giant congenital nevi: beyond NRAS mutations
VM da Silva, E Martinez-Barrios, G Tell-Martí, M Dabad, C Carrera, ...
Journal of Investigative Dermatology 139 (4), 900-908, 2019
722019
Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers
F Cuéllar, S Puig, I Kolm, J Puig‐Butille, P Zaballos, R Martí‐Laborda, ...
British Journal of Dermatology 160 (1), 48-53, 2009
652009
Development and validation of the new HER2DX assay for predicting pathological response and survival outcome in early-stage HER2-positive breast cancer
A Prat, V Guarneri, T Pascual, F Braso-Maristany, E Sanfeliu, L Pare, ...
EBioMedicine 75, 2022
642022
Genetic alterations in RAS‐regulated pathway in acral lentiginous melanoma
JA Puig‐Butillé, C Badenas, Z Ogbah, C Carrera, P Aguilera, J Malvehy, ...
Experimental dermatology 22 (2), 148-150, 2013
632013
The MC1R melanoma risk variant p.R160W is associated with Parkinson disease
G Tell‐Marti, JA Puig‐Butille, M Potrony, C Badenas, M Mila, J Malvehy, ...
Annals of neurology 77 (5), 889-894, 2015
612015
Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom
M Harland, AE Cust, C Badenas, YM Chang, EA Holland, P Aguilera, ...
Hereditary cancer in clinical practice 12, 1-10, 2014
612014
The system can't perform the operation now. Try again later.
Articles 1–20